Reported Earnings • May 01
Full year 2025 earnings released: EPS: CN¥0.38 (vs CN¥0.43 in FY 2024) Full year 2025 results: EPS: CN¥0.38. Revenue: CN¥6.49b (up 6.6% from FY 2024). Net income: CN¥194.8m (flat on FY 2024). Profit margin: 3.0% (down from 3.2% in FY 2024). The decrease in margin was driven by higher expenses. Annuncio • Apr 30
Orinko Advanced Plastics Co.,LTD, Annual General Meeting, May 27, 2026 Orinko Advanced Plastics Co.,LTD, Annual General Meeting, May 27, 2026, at 14:30 China Standard Time. Location: 4F, No. 2, Luhua Road, Baiyan Science and Technology Park, Hi-tech Zone, Hefei, Anhui China Annuncio • Mar 30
Orinko Advanced Plastics Co.,LTD to Report Q1, 2026 Results on Apr 30, 2026 Orinko Advanced Plastics Co.,LTD announced that they will report Q1, 2026 results on Apr 30, 2026 Reported Earnings • Mar 05
Full year 2025 earnings released: EPS: CN¥0.41 (vs CN¥0.43 in FY 2024) Full year 2025 results: EPS: CN¥0.41. Revenue: CN¥6.48b (up 6.4% from FY 2024). Net income: CN¥205.7m (up 6.0% from FY 2024). Profit margin: 3.2% (in line with FY 2024). Annuncio • Dec 26
Orinko Advanced Plastics Co.,LTD to Report Fiscal Year 2025 Results on Apr 30, 2026 Orinko Advanced Plastics Co.,LTD announced that they will report fiscal year 2025 results on Apr 30, 2026 Reported Earnings • Oct 30
Third quarter 2025 earnings released: EPS: CN¥0.12 (vs CN¥0.13 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.12. Revenue: CN¥1.70b (up 9.0% from 3Q 2024). Net income: CN¥61.0m (up 6.9% from 3Q 2024). Profit margin: 3.6% (down from 3.7% in 3Q 2024). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Buy Or Sell Opportunity • Oct 13
Now 20% undervalued Over the last 90 days, the stock has risen 14% to CN¥12.80. The fair value is estimated to be CN¥16.06, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.7% over the last 3 years. Earnings per share has grown by 47%. Revenue is forecast to grow by 33% in 2 years. Earnings are forecast to grow by 87% in the next 2 years. Annuncio • Sep 30
Orinko Advanced Plastics Co.,LTD to Report Q3, 2025 Results on Oct 30, 2025 Orinko Advanced Plastics Co.,LTD announced that they will report Q3, 2025 results on Oct 30, 2025 New Risk • Sep 13
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 35% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks High level of debt (50% net debt to equity). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (22% increase in shares outstanding). Valuation Update With 7 Day Price Move • Aug 15
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥14.65, the stock trades at a forward P/E ratio of 26x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 26% over the past three years. New Risk • Jul 26
New minor risk - Shareholder dilution The company's shareholders have been diluted in the past year. Increase in shares outstanding: 22% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (15% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Shareholders have been diluted in the past year (22% increase in shares outstanding). Annuncio • Jun 30
Orinko Advanced Plastics Co.,LTD to Report First Half, 2025 Results on Aug 30, 2025 Orinko Advanced Plastics Co.,LTD announced that they will report first half, 2025 results on Aug 30, 2025 Declared Dividend • Jun 23
Dividend increased to CN¥0.15 Dividend of CN¥0.15 is 50% higher than last year. Ex-date: 26th June 2025 Payment date: 26th June 2025 Dividend yield will be 1.2%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (34% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 11% per year over the past 4 years. However, payments have been volatile during that time. EPS is expected to grow by 97% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Annuncio • May 13
Orinko Advanced Plastics Co.,LTD, Annual General Meeting, Jun 03, 2025 Orinko Advanced Plastics Co.,LTD, Annual General Meeting, Jun 03, 2025, at 14:30 China Standard Time. Location: 5F, Office Building, Northwest Corner, Intersection of Changning Avenue and Ningxi Road, Baiyan Science and Technology Park, Hi-tech Zone, Hefei, Anhui China Reported Earnings • Apr 24
First quarter 2025 earnings released: EPS: CN¥0.11 (vs CN¥0.10 in 1Q 2024) First quarter 2025 results: EPS: CN¥0.11 (up from CN¥0.10 in 1Q 2024). Revenue: CN¥1.47b (up 15% from 1Q 2024). Net income: CN¥49.6m (up 15% from 1Q 2024). Profit margin: 3.4% (in line with 1Q 2024). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Apr 07
Investor sentiment deteriorates as stock falls 20% After last week's 20% share price decline to CN¥9.69, the stock trades at a trailing P/E ratio of 23.3x. Average trailing P/E is 37x in the Chemicals industry in China. Total returns to shareholders of 9.6% over the past three years. Annuncio • Mar 28
Orinko Advanced Plastics Co.,LTD to Report Q1, 2025 Results on Apr 23, 2025 Orinko Advanced Plastics Co.,LTD announced that they will report Q1, 2025 results on Apr 23, 2025 Reported Earnings • Mar 02
Full year 2024 earnings released: EPS: CN¥0.43 (vs CN¥0.33 in FY 2023) Full year 2024 results: EPS: CN¥0.43 (up from CN¥0.33 in FY 2023). Revenue: CN¥6.09b (up 14% from FY 2023). Net income: CN¥194.1m (up 32% from FY 2023). Profit margin: 3.2% (up from 2.7% in FY 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. New Risk • Feb 20
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (15% operating cash flow to total debt). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (8.4% average weekly change). Valuation Update With 7 Day Price Move • Feb 20
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥13.69, the stock trades at a trailing P/E ratio of 33.4x. Average trailing P/E is 34x in the Chemicals industry in China. Total returns to shareholders of 30% over the past three years. Annuncio • Dec 27
Orinko Advanced Plastics Co.,LTD to Report Fiscal Year 2024 Results on Apr 23, 2025 Orinko Advanced Plastics Co.,LTD announced that they will report fiscal year 2024 results on Apr 23, 2025 Valuation Update With 7 Day Price Move • Dec 10
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to CN¥12.23, the stock trades at a trailing P/E ratio of 29.6x. Average trailing P/E is 37x in the Chemicals industry in China. Total returns to shareholders of 2.5% over the past three years. Annuncio • Nov 21
Orinko Advanced Plastics Co.,LTD (SHSE:688219) announces an Equity Buyback for CNY 100 million worth of its shares. Orinko Advanced Plastics Co.,LTD (SHSE:688219) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its shares. The shares will be repurchased at no more than CNY 10 per share. The company intends to use 50% of repurchased shares for the purpose of using it for equity incentives/employee stock ownership plans and 50% repurchased shares will be cancelled to reduce registered capital. The program will be funded from own funds or self raised funds. The program is subject to approval from Shareholders. The program will be valid for 12 months from the date of approval from shareholders. Reported Earnings • Oct 30
Third quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.098 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.13 (up from CN¥0.098 in 3Q 2023). Revenue: CN¥1.56b (up 7.0% from 3Q 2023). Net income: CN¥57.1m (up 17% from 3Q 2023). Profit margin: 3.7% (up from 3.4% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 48% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment improves as stock rises 29% After last week's 29% share price gain to CN¥8.60, the stock trades at a trailing P/E ratio of 21.8x. Average trailing P/E is 30x in the Chemicals industry in China. Total loss to shareholders of 32% over the past three years. Annuncio • Sep 30
Orinko Advanced Plastics Co.,LTD to Report Q3, 2024 Results on Oct 30, 2024 Orinko Advanced Plastics Co.,LTD announced that they will report Q3, 2024 results on Oct 30, 2024 Reported Earnings • Aug 04
Second quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.11 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.11. Revenue: CN¥1.46b (up 9.1% from 2Q 2023). Net income: CN¥52.2m (up 10% from 2Q 2023). Profit margin: 3.6% (in line with 2Q 2023). Annuncio • Jun 28
Orinko Advanced Plastics Co.,LTD to Report First Half, 2024 Results on Jul 31, 2024 Orinko Advanced Plastics Co.,LTD announced that they will report first half, 2024 results on Jul 31, 2024 Annuncio • May 26
Orinko Advanced Plastics Co.,LTD, Annual General Meeting, Jun 14, 2024 Orinko Advanced Plastics Co.,LTD, Annual General Meeting, Jun 14, 2024, at 14:30 China Standard Time. New Risk • May 23
New major risk - Revenue and earnings growth Earnings have declined by 8.6% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 8.6% per year over the past 5 years. Minor Risk Dividend is not well covered by cash flows (dividend per share is over 10x cash flows per share). Reported Earnings • Apr 24
First quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.04 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.10 (up from CN¥0.04 in 1Q 2023). Revenue: CN¥1.28b (up 14% from 1Q 2023). Net income: CN¥43.2m (up 141% from 1Q 2023). Profit margin: 3.4% (up from 1.6% in 1Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 22% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 22% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Apr 03
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥9.41, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 43% over the past three years. Annuncio • Mar 30
Orinko Advanced Plastics Co.,LTD. to Report Q1, 2024 Results on Apr 23, 2024 Orinko Advanced Plastics Co.,LTD. announced that they will report Q1, 2024 results on Apr 23, 2024 Reported Earnings • Feb 24
Full year 2023 earnings: Revenues and EPS in line with analyst expectations Full year 2023 results: EPS: CN¥0.34 (up from CN¥0.13 in FY 2022). Revenue: CN¥5.34b (up 3.2% from FY 2022). Net income: CN¥153.4m (up 159% from FY 2022). Profit margin: 2.9% (up from 1.1% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 20% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 20% per year whereas the company’s share price has fallen by 22% per year. Valuation Update With 7 Day Price Move • Feb 02
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to CN¥7.50, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 53% over the past three years. New Risk • Oct 29
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.7x net interest cover). Earnings have declined by 10% per year over the past 5 years. Minor Risk Large one-off items impacting financial results. Reported Earnings • Oct 26
Third quarter 2023 earnings released: EPS: CN¥0.098 (vs CN¥0.03 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.098 (up from CN¥0.03 in 3Q 2022). Revenue: CN¥1.46b (up 10.0% from 3Q 2022). Net income: CN¥49.0m (up 297% from 3Q 2022). Profit margin: 3.4% (up from 0.9% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. New Risk • Aug 07
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 67% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (2.0x net interest cover). Earnings have declined by 15% per year over the past 5 years. Minor Risk Large one-off items impacting financial results. Reported Earnings • Jul 28
Second quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.001 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.11 (up from CN¥0.001 in 2Q 2022). Revenue: CN¥1.33b (up 14% from 2Q 2022). Net income: CN¥47.2m (up CN¥46.5m from 2Q 2022). Profit margin: 3.5% (up from 0.1% in 2Q 2022). The increase in margin was driven by higher revenue. Annuncio • Jun 28
Orinko Advanced Plastics Co.,LTD. to Report First Half, 2023 Results on Jul 28, 2023 Orinko Advanced Plastics Co.,LTD. announced that they will report first half, 2023 results on Jul 28, 2023 Reported Earnings • Apr 29
First quarter 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.07 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.04 (down from CN¥0.07 in 1Q 2022). Revenue: CN¥1.12b (down 12% from 1Q 2022). Net income: CN¥18.0m (down 42% from 1Q 2022). Profit margin: 1.6% (down from 2.4% in 1Q 2022). The decrease in margin was driven by lower revenue. Reported Earnings • Mar 02
Full year 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.12 in FY 2021) Full year 2022 results: EPS: CN¥0.13 (up from CN¥0.12 in FY 2021). Revenue: CN¥5.18b (up 5.6% from FY 2021). Net income: CN¥60.1m (up 11% from FY 2021). Profit margin: 1.2% (up from 1.1% in FY 2021). The increase in margin was driven by higher revenue. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Ruiwen Zhang was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 28
Third quarter 2022 earnings released: EPS: CN¥0.03 (vs CN¥0.005 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.03 (up from CN¥0.005 in 3Q 2021). Revenue: CN¥1.32b (up 11% from 3Q 2021). Net income: CN¥12.4m (up 319% from 3Q 2021). Profit margin: 0.9% (up from 0.2% in 3Q 2021). Reported Earnings • Aug 31
Second quarter 2022 earnings released: EPS: CN¥0.001 (vs CN¥0.028 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.001 (down from CN¥0.028 in 2Q 2021). Revenue: CN¥1.17b (flat on 2Q 2021). Net income: CN¥638.2k (down 95% from 2Q 2021). Profit margin: 0.1% (down from 1.0% in 2Q 2021). Annuncio • May 19
Orinko Advanced Plastics Co.,LTD. (SHSE:688219) announces an Equity Buyback for 10,000,000 shares, representing 2.18% for CNY 100 million. Orinko Advanced Plastics Co.,LTD. announces a share repurchase program. Under the program, the company will repurchase up to 10,000,000 shares, representing 2.18% for worth CNY 100 million. The offer price is CNY 10 per share. The repurchased shares will be used for the implementation of employee stock ownership plans and/or equity incentives. Repurchases will be funded by company's own funds. The program will be valid for a period of 12 months. As of March 31, 2022, the company had 459,283,632 shares in issue. Reported Earnings • Apr 08
Full year 2021 earnings released: EPS: CN¥0.12 (vs CN¥0.44 in FY 2020) Full year 2021 results: EPS: CN¥0.12 (down from CN¥0.44 in FY 2020). Revenue: CN¥4.90b (up 19% from FY 2020). Net income: CN¥54.1m (down 70% from FY 2020). Profit margin: 1.1% (down from 4.4% in FY 2020). Reported Earnings • Feb 27
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: EPS: CN¥0.12 (down from CN¥0.44 in FY 2020). Revenue: CN¥4.90b (up 19% from FY 2020). Net income: CN¥54.5m (down 70% from FY 2020). Profit margin: 1.1% (down from 4.4% in FY 2020). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Reported Earnings • Aug 31
Second quarter 2021 earnings released: EPS CN¥0.028 (vs CN¥0.12 in 2Q 2020) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥1.17b (up 11% from 2Q 2020). Net income: CN¥11.7m (down 76% from 2Q 2020). Profit margin: 1.0% (down from 4.6% in 2Q 2020). Valuation Update With 7 Day Price Move • Aug 31
Investor sentiment deteriorated over the past week After last week's 21% share price decline to CN¥15.02, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 21x in the Chemicals industry in China. Valuation Update With 7 Day Price Move • Jul 12
Investor sentiment improved over the past week After last week's 21% share price gain to CN¥21.07, the stock trades at a trailing P/E ratio of 46.8x. Average trailing P/E is 30x in the Chemicals industry in China. Reported Earnings • Apr 19
Full year 2020 earnings released: EPS CN¥0.44 (vs CN¥0.30 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥4.12b (up 2.3% from FY 2019). Net income: CN¥182.2m (up 67% from FY 2019). Profit margin: 4.4% (up from 2.7% in FY 2019). Valuation Update With 7 Day Price Move • Dec 28
Investor sentiment deteriorated over the past week After last week's 18% share price decline to CN¥18.97, the stock is trading at a trailing P/E ratio of 44.9x, down from the previous P/E ratio of 54.7x. This compares to an average P/E of 35x in the Chemicals industry in China. 
